DRL sells brand Sernivo; grants Promiseb and Trianex US marketing rights to Encore Dermatology
Posted on03 Apr 2019
Comments0
Dr. Reddy’s Laboratories Limited through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for Sernivo (betamethasone dipropionate)... Read More